IDiyas

For the Inventor, By the Inventor

Marburg, Germany

Aventis Behring Gmbh


USPTO Granted Patents = 57


Trademarks = 3

Forward Citations = 1,163

Loading Chart...
Loading Chart...

96 inventors (with patents filed for the assignee):

goldMedal Jürgen Römisch (10 out of 11 patents)

silverMedal Alain Fournier (8 out of 27 patents)

bronzeMedal Jean-Dominique Guitton (8 out of 13 patents)

4.  Patrice Yeh (8 out of 37 patents)

5.  Reinhard Fleer (8 out of 21 patents)

6.  Annette Feussner (7 out of 18 patents)

7.  Gérard Jung (7 out of 15 patents)

8.  Juergen Roemisch (6 out of 13 patents)

9.  Harald Stauss (6 out of 6 patents)

10.  Thomas Weimer (5 out of 27 patents)

11.  Hans-Arnold Stoehr (5 out of 12 patents)

12.  Gerhard Dickneite (4 out of 29 patents)

13.  Hubert Metzner (4 out of 28 patents)

14.  Claude Négrier (4 out of 4 patents)

15.  Peter Gronski (3 out of 5 patents)


Core Competencies:
Medical Fluid Transfer Device
Pathogenic Prions Detection
Factor VII Activating Protease
Fusion Proteins
Erythropoietin Treatment
Gene Manipulation
Antithrombin III Preparation
Tissue Adhesives
Polynucleotide Amplification
Virus Inactivation
Blood Coagulation Factors
Fibrin Solutions

57 patents:

1. 8197459 - Self-sealing medical fluid transfer device (2012-06-12),
2. 7202021 - Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies (2007-04-10),
3. 7153679 - Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis (2006-12-26),
4. 7094577 - Insulin and albumin fusion protein (2006-08-22),
5. 7081354 - Interleukin and albumin fusion protein (2006-07-25),
6. 7056701 - Hormone and albumin fusion protein (2006-06-06),
7. 7041478 - G-CSF and albumin fusion protein (2006-05-09),
8. 6989365 - Methods of treatment with erythropoietin and albumin fusion protein (2006-01-24),
9. 6987006 - Erythropoietin and albumin fusion protein, nucleic acids, and methods thereof (2006-01-17),
10. 6972322 - Interferon and albumin fusion protein (2005-12-06),
11. 6869790 - Preparation of DNA encoding factor XIIIA (2005-03-22),
12. 6831167 - Mutants of the factor VII-activating protease and detection methods using specific antibodies (2004-12-14),
13. 6829875 - Method of venting a filled bottle which is closed by means of an elastic stopper, and apparatus for implementing the method (2004-12-14),
14. 6800461 - Modified factor VIII cDNA (2004-10-05),
15. 6790832 - Pharmaceutical preparation for the treatment of inflammatory processes (2004-09-14),
Aventis Behring GmbH is a global biopharmaceutical company specializing in the development, production, and distribution of innovative therapies. With a focus on rare and life-threatening diseases, Aventis Behring strives to improve patient outcomes and quality of life. Our dedicated team of researchers, scientists, and healthcare professionals work tirelessly to discover breakthrough treatments and bring them to the market. Visit our website to learn more about our mission, products, and commitment to advancing healthcare.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

57 Patents

#6 in Marburg

#973 in Germany

#12,145 in the World

...
Marburg, Germany

Aventis Behring Gmbh

Forward Citations = 1,163

96 inventors:

goldMedal Jürgen Römisch (10 out of 11 patents)

silverMedal Alain Fournier (8 out of 27 patents)

bronzeMedal Jean-Dominique Guitton (8 out of 13 patents)

4.  Patrice Yeh (8 out of 37 patents)

5.  Reinhard Fleer (8 out of 21 patents)

Please report any incorrect information to support@idiyas.com
Loading…